Botulinum toxin type-B improves sialorrhea and quality of life in bulbaronset amyotrophic lateral sclerosis

The SWAL-QOL Outcomes Tool for Oropharyngeal Dysphagia in Adults: I. Conceptual Foundation and Item Development

Colleen A. McHorney, D. Earl Bricker, Amy E. Kramer et al. · Dysphagia · 2000 · 369 citations

Medicine, Otolaryngology, Speech-language Pathology +14

Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia

Cynthia Comella, Joseph Jankovic, Kathleen M. Shannon et al. · Neurology · 2005 · 249 citations

Medicine, Neurology, Cervical Disease +15

A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease

William G. Ondo, Christine Hunter, Warren H. Moore · Neurology · 2004 · 239 citations

Medicine, Neurology, Pharmacotherapy +17

Double‐blind, placebo‐controlled study to evaluate the efficacy and safety of botulinum toxin type A in the treatment of drooling in parkinsonism

Francesca Mancini, Roberta Zangaglia, Silvano Cristina et al. · Movement Disorders · 2003 · 237 citations

Medicine, Neurology, Pharmacotherapy +14

Sialorrhea: a management challenge.

Neil Hockstein, Daniel S. Samadi, Kristin Gendron et al. · PubMed · 2004 · 204 citations

Dentistry, Oral Medicine, Speech-language Pathology +15